Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking

被引:8
|
作者
Mangla, Priyanka [1 ]
Vicentini, Quentin [1 ,2 ]
Biscans, Annabelle [1 ]
机构
[1] AstraZeneca, Oligonucleotide Discovery, Discovery Sci Res & Dev, S-43138 Gothenburg, Sweden
[2] Karolinska Inst, Clin Res Ctr, Dept Lab Med, S-14157 Stockholm, Sweden
基金
欧盟地平线“2020”;
关键词
oligonucleotide therapeutics; antisense oligonucleotides (ASOs); siRNA; oligonucleotide delivery; endosomal escape; endosomolytic agents; oligonucleotide conjugates; linker chemistry; non-cleavable linkers; cleavable linkers; pH-sensitive linkers; CELL-PENETRATING PEPTIDES; IN-VIVO DELIVERY; GENE SILENCING ACTIVITY; ARGININE-RICH PEPTIDES; NUCLEIC-ACIDS; SIRNA DELIVERY; MEDIATED DELIVERY; NONVIRAL VECTORS; ANTISENSE OLIGONUCLEOTIDES; PHYSICOCHEMICAL PROPERTIES;
D O I
10.3390/cells12182253
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The potential of oligonucleotide therapeutics is undeniable as more than 15 drugs have been approved to treat various diseases in the liver, central nervous system (CNS), and muscles. However, achieving effective delivery of oligonucleotide therapeutics to specific tissues still remains a major challenge, limiting their widespread use. Chemical modifications play a crucial role to overcome biological barriers to enable efficient oligonucleotide delivery to the tissues/cells of interest. They provide oligonucleotide metabolic stability and confer favourable pharmacokinetic/pharmacodynamic properties. This review focuses on the various chemical approaches implicated in mitigating the delivery problem of oligonucleotides and their limitations. It highlights the importance of linkers in designing oligonucleotide conjugates and discusses their potential role in escaping the endosomal barrier, a bottleneck in the development of oligonucleotide therapeutics.
引用
收藏
页数:38
相关论文
共 50 条
  • [31] Molecular targeting: new therapeutic strategies to improve tumour apoptosis
    Marsoni, S
    Damia, G
    ANNALS OF ONCOLOGY, 2004, 15 : 229 - 231
  • [32] Synthesis of mixed-sequence oligonucleotides on mesoporous silicon: chemical strategies and material stability
    Terracciano, Monica
    Rea, Ilaria
    Stefano, Luca De
    Rendina, Ivo
    Oliviero, Giorgia
    Nici, Fabrizia
    D'Errico, Stefano
    Piccialli, Gennaro
    Borbone, Nicola
    NANOSCALE RESEARCH LETTERS, 2014, 9 : 1 - 9
  • [33] Synthesis of mixed-sequence oligonucleotides on mesoporous silicon: chemical strategies and material stability
    Monica Terracciano
    Ilaria Rea
    Luca De Stefano
    Ivo Rendina
    Giorgia Oliviero
    Fabrizia Nici
    Stefano D'Errico
    Gennaro Piccialli
    Nicola Borbone
    Nanoscale Research Letters, 9
  • [34] Epigenetic modulation of NK cells to improve tumor trafficking and enhance therapeutic efficacy against osteosarcoma
    Anjier, Ariana Rupp
    Gordon, Nancy
    Maegawa, Shinji
    Gopalakrishnan, Vidya
    Bournat, Juan
    Cheng, Donghang
    Yang, Yanwen
    Kingsley, Charles
    Kulp, Adam
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Phycocyanin and phycoerythrin: Strategies to improve production yield and chemical stability
    Hsieh-Lo, Ming
    Castillo, Gustavo
    Alberto Ochoa-Becerra, Mario
    Mojica, Luis
    ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2019, 42
  • [36] Hsc70 Facilitates Mannose-6-Phosphate Receptor-Mediated Intracellular Trafficking and Enhances Endosomal Release of Phosphorothioate-Modified Antisense Oligonucleotides
    Liang, Xue-Hai
    Nichols, Joshua G.
    Hsu, Chih-Wei
    Crooke, Stanley T.
    NUCLEIC ACID THERAPEUTICS, 2021, 31 (04) : 284 - 297
  • [37] Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases
    Silva, Luisa H. A.
    Antunes, Mariana A.
    Dos Santos, Claudia C.
    Weiss, Daniel J.
    Cruz, Fernanda F.
    Rocco, Patricia R. M.
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [38] Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases
    Luisa H. A. Silva
    Mariana A. Antunes
    Claudia C. Dos Santos
    Daniel J. Weiss
    Fernanda F. Cruz
    Patricia R. M. Rocco
    Stem Cell Research & Therapy, 9
  • [39] Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies
    R. C. Heijkants
    M. Nieveen
    K. C.’t Hart
    A. F. A. S. Teunisse
    A. G. Jochemsen
    Oncogenesis, 7
  • [40] Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review)
    Chen, Meihong
    Li, Hui
    Li, Yun
    Luo, Yangui
    He, Yuan
    Shui, Xiaorong
    Lei, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 54 (06)